TRADING UPDATES: EnSilica hails "solid" half-year; Aptamer revenue up
7th Jan 2026 11:43
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 0.245p on 06-02-2026 at 19:40:09 |
|---|---|
| Change | 0.01p 4.17% |
| Buy | 0.25p |
| Sell | 0.24p |
| Last Trade: | Buy 84,484.00 at 0.25p |
| Day's Volume: | 40,520,595 |
| Last Close: | 0.25p |
| Open: | 0.245p |
| ISIN: | GB00BMD1Z199 |
| Day's Range | 0.24p - 0.255p |
| 52wk Range: | 0.1095p - 0.395p |
| Market Capitalisation: | £17.02m |
| VWAP: | 0.24299p |
| Shares in Issue: | 6.81b |
Sector: Medicine and Biotech
Solvonis Therap (SVNS) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 84,484 | 0.25p | Suspected BUY Trade |
16:35:05 - 06-Feb-26 |
| Buy* | 295,080 | 0.2497p | Ordinary |
16:03:51 - 06-Feb-26 |
| Buy* | 97,116 | 0.25p | Ordinary |
15:51:01 - 06-Feb-26 |
| Buy* | 545,005 | 0.2452p | Ordinary |
14:57:23 - 06-Feb-26 |
| Buy* | 8,000,000 | 0.25p | Ordinary |
14:56:22 - 06-Feb-26 |
| Buy* | 199,884 | 0.2489p | Ordinary |
14:53:54 - 06-Feb-26 |
| Buy* | 26,085 | 0.25p | SI Trade |
14:49:13 - 06-Feb-26 |
| Buy* | 6,368 | 0.25p | SI Trade |
14:49:13 - 06-Feb-26 |
| Buy* | 396 | 0.25p | SI Trade |
14:49:13 - 06-Feb-26 |
| Buy* | 51,634 | 0.25p | SI Trade |
14:49:13 - 06-Feb-26 |
Solvonis Therap (SVNS) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 28th Jan 2026 7:00 am | RNS | Expansion of SVN-015 into depression |
| 7th Jan 2026 7:00 am | RNS | US Patent allowance for PTSD discovery programme |
| 22nd Dec 2025 7:00 am | RNS | Research and Development Update - Q4 2025 |
| 22nd Dec 2025 7:00 am | RNS | Research and Development Update – Q4 2025 |
| 3rd Dec 2025 7:00 am | RNS | SVN-015 accepted into US NIDA funded programme |
| 31st Oct 2025 3:59 pm | RNS | Total Voting Rights |
| 31st Oct 2025 7:00 am | RNS | Corporate Structure Update and Issue of Options |
| 27th Oct 2025 7:00 am | RNS | Appoints global biopharma leader Paul Carter |
| 16th Oct 2025 7:00 am | RNS | Raises £1.25 Million to Accelerate Programmes |
| 30th Sep 2025 7:00 am | RNS | Half-year Report |